ELBASVIR/GRAZOPREVIR IN CHILDREN AGED 3 TO < 18 YEARS WITH CHRONIC HEPATITIS C VIRUS (HCV) GENOTYPE (GT) 1 OR 4 INFECTION: FINAL RESULTS FROM AN ITERATIVE PHARMACOKINETIC (PK) MODELING STUDY Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Wirth, Stefan; Gonzalez-Peralta, Regino P.; Squires, Robert H.; Mutschler, Frauke; Lang, Thomas; Pawlowska, Malgorzata; Sluzewskr, Wojciech; Majda-Stanislawska, Ewa; Fischler, Bjorn; Balistreri, William; Jonas, Maureen M.; Blondet, Niviann; Rosenthal, Philip; Alkhouri, Naim; Romero, Rene; Grandhi, Anjana; Castronuovo, Patricia; Caro, Luzelena; Rosenbloom, Daniel; Du, Lihong; Haber, Barbara

authors

Publication Date

  • November 1, 2020

webpage

published in

category

start page

  • 555A

end page

  • 556A

volume

  • 72